{"disease":{"id":"primary-sclerosing-cholangitis","name":"primary sclerosing cholangitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05618145","title":"National Database on Primary Sclerosing Cholangitis (PSC)","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT06519162","title":"Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Chungnam National University Hospital","has_results":false},{"nct_id":"NCT05740358","title":"Liver Cirrhosis Network Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1222,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04181138","title":"Primary Sclerosing Cholangitis in Children","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Arbor Research Collaborative for Health","has_results":false},{"nct_id":"NCT05463445","title":"Multicenter Observational Study of PSC and IgG4-SC in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT05750498","title":"A-LiNK: Improving Outcomes in Autoimmune Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03041662","title":"Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)","phase":"","overall_status":"COMPLETED","enrollment_count":620,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT04133792","title":"Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":571,"lead_sponsor_name":"Annika Bergquist","has_results":false},{"nct_id":"NCT03890120","title":"Study of Cilofexor in Adults With Primary Sclerosing Cholangitis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":419,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT05181332","title":"Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT07387549","title":"A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":350,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT04753996","title":"Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT01672853","title":"Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":235,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03337074","title":"Paternally Inherited Phenotypes in Cholestasis","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT04685200","title":"Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach","phase":"","overall_status":"RECRUITING","enrollment_count":143,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT07229911","title":"A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":134,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04480840","title":"Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Pliant Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03146936","title":"Swiss Primary Sclerosing Cholangitis Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Fondazione Epatocentro Ticino","has_results":false},{"nct_id":"NCT06686810","title":"Endoscopy and Primary Sclerosing Cholangitis","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03175471","title":"MRI Based Biomarkers in Pediatric Autoimmune Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT06975150","title":"Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":105,"lead_sponsor_name":"CuromeBiosciences","has_results":false},{"nct_id":"NCT02712736","title":"Quality of Life in Patients With Primary Sclerosing Cholangitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03710122","title":"Vancomycin for Primary Sclerosing Cholangitis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Elizabeth Carey","has_results":false},{"nct_id":"NCT06351696","title":"The Effects of Bromelain Supplement in Patients With Ulcerative Colitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"National Nutrition and Food Technology Institute","has_results":false},{"nct_id":"NCT06905054","title":"Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05082779","title":"Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Cascade Pharmaceuticals, Inc","has_results":false},{"nct_id":"NCT02177136","title":"Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Intercept Pharmaceuticals","has_results":true},{"nct_id":"NCT05627362","title":"A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT03743272","title":"Repeatability and Reproducibility of Multiparametric MRI","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Perspectum","has_results":false},{"nct_id":"NCT06026865","title":"S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT06026449","title":"Gluten-free Diet in PSC and IBD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Institute for Clinical and Experimental Medicine","has_results":false},{"nct_id":"NCT03333928","title":"A POC and Dose-Ranging Study of HTD1801 in PSC Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":true},{"nct_id":"NCT06286709","title":"FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":58,"lead_sponsor_name":"University of Birmingham","has_results":false},{"nct_id":"NCT02808312","title":"Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT02943460","title":"Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03766035","title":"Cholangioscopy in Primary Sclerosing Cholangitis (PSC)","phase":"","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Boston Scientific Corporation","has_results":false},{"nct_id":"NCT03809559","title":"Repeatability and Reproducibility of Quantitative MRCP","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Perspectum","has_results":false},{"nct_id":"NCT03951324","title":"Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Innovative Digestive Health Education and Research Inc","has_results":false},{"nct_id":"NCT03099603","title":"A Study of HTD1801 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":false},{"nct_id":"NCT03561584","title":"Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06197308","title":"Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT05835505","title":"Detoxification of the Liver In PSC (Dolphin)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT02653625","title":"PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Tobira Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05866809","title":"Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"CuromeBiosciences","has_results":false},{"nct_id":"NCT02239211","title":"A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"University of Birmingham","has_results":false},{"nct_id":"NCT03183570","title":"Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT04678219","title":"A Pilot Study Examining Diet in Primary Sclerosing Cholangitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03722576","title":"Vidofludimus Calcium for Primary Sclerosing Cholangitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Elizabeth Carey","has_results":true},{"nct_id":"NCT05642468","title":"Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Albireo, an Ipsen Company","has_results":false},{"nct_id":"NCT05912387","title":"Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Stanford University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}